You don't have permission to access "http://www.medpagetoday.com/publichealthpolicy/washington-watch/120957" on this server. Reference #18.9177d917.1777129350.26f9f21a https://errors.edgesuite.net/18.9177d917.1777129350.26f9f21a
Please complete security verification This request seems a bit unusual, so we need to confirm that you're human. Please press and hold the button until it turns completely green. Thank you for your cooperation! Press and hold the button If you believe this is an error, please contact our support team. 185.149.70.50 : 04deca68-dc17-41a1-9866-49a6580b
Public health officials are taking aim at the Food and Drug Administration (FDA), warning it should not bow to political pressure and clear a COVID-19 vaccine before one is ready. The officials say they are unnerved over the pressure cranked up by the president, and worry it will contribute to distrust in the public health system that could actually…
More good news on progress towards an escape route from this pandemic: On Monday, vaccine researchers from Oxford University and the pharmaceutical company AstraZeneca announced results from a “Phase 1/2 trial,” suggesting their product might be able to generate immunity without causing serious harm. Similar, but smaller-scale results, were posted just last week for another…
Leaders and laggards in the COVID-19 vaccine race -- and how likely they are to win approval. When will a COVID-19 vaccine be available? How effective will it be? Those are two of the most pressing questions being asked by many with the number of COVID-19 cases rising in much of the U.S. Unfortunately, the…
Healthcare affordability. Abortion access. “Medicare for All.” Healthcare was a major force behind the big wins for Democrats in this week’s midterm elections. But the debate over what the Democratic Party will do next is just getting started. KFF Health News chief Washington correspondent Julie Rovner appeared on WAMU’s Health Hub on Nov. 4 to
Generated November 2026 · Clinical Deep Dive Four Fibromyalgia Drugs Are Approved in the US, None in Europe. What Are Regulators Seeing Differently? 0 Comments Your fibromyalgia patient has a diagnosis, a playbook, and a prescription. Only some of that stands on firm ground. The FDA has approved four drugs for fibromyalgia, European regulators refused
You don't have permission to access "http://www.medpagetoday.com/popmedicine/popmedicine/123739" on this server. Reference #18.cb94d817.1793916100.1551aa8 https://errors.edgesuite.net/18.cb94d817.1793916100.1551aa8